来自英国首批Omnipod 5用户的真实世界数据：一项单中心观察性研究。 - Suppr | 超能文献

相似文献

1

Real-world data from first UK Omnipod 5 users: A single-centre observational study.来自英国首批Omnipod 5用户的真实世界数据：一项单中心观察性研究。

Diabetes Obes Metab. 2024 Aug;26(8):3462-3465. doi: 10.1111/dom.15629. Epub 2024 May 2.

2

Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes mellitus in the United Kingdom.英国2型糖尿病患者口服降糖单药治疗依从性的相关因素。

Diabetes Res Clin Pract. 2015 Sep;109(3):e27-31. doi: 10.1016/j.diabres.2015.05.031. Epub 2015 May 14.

3

Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data.预混胰岛素与基础-餐时胰岛素方案治疗 2 型糖尿病的临床结局比较：随机对照试验与真实世界数据比较。

Diabet Med. 2017 Dec;34(12):1728-1736. doi: 10.1111/dme.13518. Epub 2017 Oct 14.

4

How many people inject insulin? UK estimates from 1991 to 2010.有多少人注射胰岛素？英国 1991 年至 2010 年的估计数据。

Diabetes Obes Metab. 2014 Jun;16(6):553-9. doi: 10.1111/dom.12260. Epub 2014 Feb 9.

5

Real-World Evidence of Omnipod 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes.69902例1型糖尿病患者使用Omnipod 5自动胰岛素输送系统的真实世界证据。

Diabetes Technol Ther. 2024 Aug;26(8):514-525. doi: 10.1089/dia.2023.0578. Epub 2024 Feb 16.

6

PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 Diabetes.先驱真实英国研究：一项多中心、前瞻性、真实世界研究，评估每日一次口服司美格鲁肽在 2 型糖尿病成人患者中的应用。

Adv Ther. 2024 Nov;41(11):4266-4281. doi: 10.1007/s12325-024-02973-z. Epub 2024 Sep 24.

7

Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme.在中国和英国进行的一项全国性医生和患者报告的横断面调查（疾病特定项目）有效性的证据。

BMJ Open. 2016 Aug 16;6(8):e010352. doi: 10.1136/bmjopen-2015-010352.

8

Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus.在英国初级保健环境中，与早期与晚期使用达格列净强化治疗相比，2 型糖尿病患者的血糖、体重和血压变化。

Diabetes Res Clin Pract. 2019 Sep;155:107791. doi: 10.1016/j.diabres.2019.107791. Epub 2019 Jul 17.

9

Canadian Real-World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry.加拿大 1 型糖尿病患者使用 Omnipod 起始治疗的真实世界结局（COPPER 研究）：来自 LMC 糖尿病登记处的证据。

Diabet Med. 2021 Jun;38(6):e14420. doi: 10.1111/dme.14420. Epub 2020 Oct 22.

10

A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance.U500 胰岛素经 Omnipod 给药治疗 2 型糖尿病伴严重胰岛素抵抗患者的前瞻性试验。

Endocr Pract. 2010 Sep-Oct;16(5):778-84. doi: 10.4158/EP10014.OR.

引用本文的文献

1

Ethnicity and socioeconomic status do not influence glycaemic outcomes of a tubeless hybrid closed-loop system (Omnipod® 5) in adults with type 1 diabetes.种族和社会经济地位不会影响1型糖尿病成年患者使用无管混合闭环系统（Omnipod® 5）的血糖控制效果。

Diabetes Obes Metab. 2025 Sep;27(9):5052-5063. doi: 10.1111/dom.16553. Epub 2025 Jul 9.

2

Safety, efficacy and psychological impact of Omnipod hybrid closed loop system in children, adolescents, and adults in 24 h and nighttime: Systematic review with additional meta-analysis.Omnipod混合闭环系统在儿童、青少年和成人24小时及夜间的安全性、有效性和心理影响：系统评价及附加荟萃分析

J Diabetes Metab Disord. 2025 May 30;24(1):134. doi: 10.1007/s40200-025-01639-z. eCollection 2025 Jun.

3